MedPath

Effects of Nitrates and Citrulline Malate on Performance in Professional Professional Soccer

Not Applicable
Completed
Conditions
Supplementation
Interventions
Dietary Supplement: Control product
Dietary Supplement: Nitrates and Citrulline Malate
Registration Number
NCT05525871
Lead Sponsor
Universidad CatĂłlica San Antonio de Murcia
Brief Summary

Randomized, single-center, parallel, team-stratified, stratified experimental study to evaluate the efficacy of a high sports supplement in improving high-intensity intermittent exercise performance in professional female soccer players.

Detailed Description

Subjects who meet the selection criteria will be randomly assigned to each of the study groups (investigational product or placebo, depending on the group to which they have been assigned).

The product to be consumed will be Nitrates and Citrulline Malate. Participants will consume the product for 30 days. The intake should be done two hours before each training session and the same dose will be consumed.

The women's soccer players will perform a stress test with gas analysis to measure performance, as well as a Wingate test without consumption of the products. Five days later, the players will perform the Yo-Yo IR1 test in the field and will repeat the same tests performed at the beginning of the test after product consumption.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Present at the time of signing the informed consent at the age between 18 and 40 years.
  • Female.
  • Healthy subjects without any chronic disease.
  • Volunteers capable of understanding the clinical study, willing to give their written informed. consent and comply with the procedures and requirements of the study. and requirements of the study.
Exclusion Criteria
  • Players who change teams during the experimental study.
  • Smoking subjects.
  • Subjects using mouthwashes during the study.
  • Subjects with a history of drug, alcohol or other substance abuse or other factors that limit their ability to cooperate during the study. factors that limit their ability to cooperate during the study.
  • Subjects whose status makes them ineligible for the study, at the discretion of the investigator discretion of the investigator.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control productControl productConsumption of placebo product (Fruit puree)
Nitrates and Citrulline MalateNitrates and Citrulline MalateGel elaborated from fruit puree with high polyphenol content, with the addition of nitrates and citrulline malate as study supplements. addition of nitrates and citrulline malate as study supplements.
Primary Outcome Measures
NameTimeMethod
Aerobic and anaerobic thresholds - VO2maxChange in initial maximal oxygen consumption at 30 days

Measured with a gas analyzer

Fatigue in jumpingChange in initial jump fatigue at 30 days

Measured with a contact platform

Anaerobic capacityChange in baseline anaerobic capacity at 30 days

Measured with a Monark cycloergometer

Secondary Outcome Measures
NameTimeMethod
Microcapillary bloodIt will be measured on two different occasions. Day one and 30 days later.

This test provides biochemical variables (ABL90FLEX) with 70 ml of capillary blood.

LactateIt will be measured on two different occasions. One on the first day (without intake of product ) and 30 days later, the same measurements but after having consumed the product

Lactate levels will be measured using the Lactate Pro

Safety variablesIt will be measured on two different occasions. Day one and 30 days later.

It is a blood test that measures the presence of some enzymes, proteins and bilirubin in the blood, with the aim of determining if there is any alteration in the liver.

Trial Locations

Locations (1)

Catholic University of Murcia

🇪🇸

Murcia, Spain

© Copyright 2025. All Rights Reserved by MedPath